CERE (Cerevel) Gross Profit Margin

CERE (Cerevel Therapeutics Inc) - company brandmark

Cerevel Therapeutics is implementing robotic bioscreening to accelerate the discovery of CNS molecules. The change in gross margin visualizes this progress, with the metric reaching 0.00. Business efficiency is based on outsourcing drug synthesis through CMO facilities, while the uniqueness of CERE lies in its targeted action on dopamine receptors for the safe treatment of Parkinson's disease.

CERE (Cerevel Therapeutics) Gross Margin history from 07/04/2022 to 08/10/2024

Financial and market metric breakdowns for Cerevel Therapeutics Inc (CERE)

Summary company analysis:Cerevel Therapeutics
Product sample of Cerevel Therapeutics, Inc.

The efficiency of developing targeted drugs for Parkinson's disease therapy directly determines the financial stability of Cerevel Therapeutics (CERE). This ratio, calculated as gross profit relative to total revenue, measures direct production yield and the business's ability to optimize costs. Investors should evaluate the asset's dynamics, noting that the gross margin rate signals whether the company is overvalued or undervalued.

Key competitors

Return on Gross Profit Biogen Corp|Return on Gross Profit NBIX|Regencell Corp (RGC) - Return on Sales by Gross Profit|Gross Margin AXSM|Return on Gross Profit ACADIA Pharmaceuticals ACAD|Gross Margin XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Gross Profitability Margin|SUPN - Gross Profitability|Catalyst Pharmaceuticals Inc (CPRX) - Return on Gross Profit|DNLI (Denali Corp) - Return on Gross Profit|Gross Profit Margin harmonybiosciences.com (HRMY)|Return on Gross Profit BHVN|Gross Margin Amylyx|Gross Margin TRVI|PRAX (Praxis Corp) - Gross Profit Rate|Gross Margin AVXL (anavex.com)|CBLL: Gross Return on Sales|PRTA - Gross Profitability|ALEC - Gross Margin|Annexon Inc. (ANNX) - Gross Profitability|Return on Gross Profit Omeros Corp|Return on Gross Profit NGNE|ACIU: Gross Profit Rate|Return on Gross Profit VYGR (Voyager Corp)|Return on Gross Profit Neumora NMRA|Gross Profitability Scilex Holding Company, Inc. SCLX|Gross Sales Margin Tevogen Bio Inc.|ACOG - Gross Profitability|Gross Sales Margin Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Return on Gross Profit|Cassava Sciences Inc (SAVA) - Gross Margin|Return on Gross Profit ASRT|Gross Margin coyatherapeutics.com|Gross Margin VTGN|Ovid Therapeutics - Gross Return on Sales|Gross Margin ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Return on Gross Profit|ATHE - Gross Profitability|Return on Sales by Gross Profit clene.com CLNN|PEPG: Gross Margin|Gross Return on Sales JUNS|RLMD (Relmada Corp) - Gross Margin|Annovis Bio Inc (ANVS) - Return on Sales by Gross Profit|Gross Profitability Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Gross Profit Rate|Gross Profitability Klotho Neurosciences KLTO|NRSN: Gross Return on Sales|RVPH: Return on Gross Profit|MTVA: Gross Profitability|NRXS (NeurAxis Inc) - Return on Gross Profit|Return on Gross Profit Helius Medical Technologies, Inc.|Gross Profitability Passage Bio Inc.|Gross Profit Margin bionomics.com.au NEUP|Gross Margin NERV|Gross Margin Athira Pharma Inc (ATHA)|Gross Margin ADXN (Addex Therapeutics Ltd.)|ALZN: Gross Return on Sales|CYCN - Gross Profitability|Gross Profit Margin Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Return on Gross Profit|Gross Sales Margin Cortigent, Inc. CRGT|Gross Profitability Avenue Therapeutics, Inc.|Return on Gross Profit BrainStorm Cell Therapeutics Inc. (BCLI)|Gross Profitability Cara Therapeutics, Inc (CARA)|Gross Profitability CHRO (Chromocell Therapeutics Corp.)|Gross Margin ELYM (eliemtx.com)|intracellulartherapies.com - Gross Profitability|LBPH: Return on Gross Profit|Gross Profit Rate MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Return on Gross Profit|Return on Gross Profit NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Gross Margin|Neurotrope - Gross Profitability Margin|Gross Margin TRVN|Return on Sales by Gross Profit Vigil Neuroscience, Inc.|Gross Profitability Anew Medical, Inc. WENA